Navigation Links
Abbott to Present New Data Across its Vascular Portfolio at the,,,American College of Cardiology's 56th Annual Scientific Session

Highlights Include First U.S. Clinical Data on XIENCE V Everolimus Eluting Coronary Stent System and Six-Month Patient Follow-Up Results from the ABSORB Bioabsorbable Stent Clinical Study

ABBOTT PARK, Ill., March 19, 2007 /PRNewswire-FirstCall/ -- Abbott will present data from several studies across its broad vascular portfolio and pipeline during a number of late-breaking clinical trial and poster sessions at the of Cardiology's 56th Annual Scientific Session being held March 24-27 in New Orleans at the Ernest N. Morial Convention Center.

Late-breaking data presentations from Abbott will include the first U.S. clinical data results from the SPIRIT III pivotal clinical trial comparing the performance at nine months of the XIENCE(TM) V Everolimus Eluting Coronary Stent System to the TAXUS(R) Paclitaxel-Eluting Coronary Stent System; six- month data from ABSORB, the world's first clinical trial of a fully bioabsorbable drug-eluting stent; and interim 30-day data from two studies designed to confirm that carotid stenting can be performed with good results by a variety of physician specialties in real-world (non-clinical trial) settings in patients who are at high risk for carotid artery surgery. In addition, one-year follow-up data on patients enrolled in the SPIRIT II clinical trial will be presented during a poster session.

SPIRIT III Nine-Month Pivotal Clinical Data Results

Late-Breaking Clinical Trials I, i2. Summit Interventional Programming Saturday, March 24, 11:30 a.m. Central Time

Room La Nouvelle Orleans C, Ernest N. Morial Convention Center

Gregg W. Stone, M.D., of Medical Center and the Cardiovascular Research Foundation, New York, will present results from the randomized portion of Abbott's SPIRIT III pivotal clinical trial. SPIRIT III is a large-scale U.S. trial designed to compare Abbott's XIENCE V Evero
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. The Past, Present and Future of HLA Typing
11. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:9/2/2015)... and TORONTO , ... ( www.generex.com ) (OTCQB: GNBT) today announced ... a buccal cannabis co-development arrangement with CannScience ... formalized. Generex and CannScience have ... Licensing Agreement.  Pursuant to the Agreement, Generex ...
(Date:9/2/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... for cancer, today announced results for its fiscal year ... http://photos.prnewswire.com/prnh/20140805/133834 "Despite a challenging end ... how the Company is positioned entering fiscal year 2016," ... Chief Executive Officer of MEI Pharma. "While we were ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
Breaking Medicine Technology:Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
(Date:9/2/2015)... ... ... to an article published August 12 by International Business Times, a new bill ... grand juries in cases meant to decide if a police officer used deadly or excessive ... in Ferguson and New York City that absolved police officers of charges in the deaths ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... from the Abraham and Mildred Goldstein Charitable Trust to establish the Abraham and ... gift comes six months after WCHN recruited nationally known gynecologic oncologist Thomas J. ...
(Date:9/2/2015)... Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... featured by the Huffington Post on August 25th, writer Akela Stanfield detailed her ... surgery. While the author acknowledged that she had always seen herself as someone who ...
(Date:9/2/2015)... Covington, LA (PRWEB) , ... September 02, 2015 ... ... new President/CEO and Regulatory Affairs Officer following the departure of Kristen Dietz, former ... Medical Officer of Healtec® released the following statement welcoming Mr. Salot: “ Stanley ...
(Date:9/2/2015)... ... 02, 2015 , ... Density measurement is used in many ... handling makes density measurements more efficient and error-free. The new METTLER TOLEDO video ... and the advantages compared to manual sample handling. , The Evolution of Density ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:Healtec® Announces Executive Leadership Change 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3
... , Front-line Caregivers, Nursing Home Residents and Their Family ... Delegation to Stop Potential Cuts , , ... , , RIO RANCHO, N.M., Aug. 11 A ... nursing home residents and their family members to sign a petition that will ...
... , , WELLESLEY HILLS, Mass., ... the PRX-07034 Therapeutics - CNS Phase 2 will be part of the ... , , The PRX-07034 Therapeutics - CNS Phase 2 ... schizophrenia (CIAS). The Company has completed Phase 1 in obesity with ...
... exercise capacity in some mountaineers, according to Swiss researchers. ... been used for years to treat altitude-related symptoms in ... to improve exercise capacity at high altitude. "We ... for preventing high altitude pulmonary edema (HAPE) and dex ...
... It doesn,t affect quality of life in most cases, review ... spares the limbs of some cancer patients may have little ... cost or quality of life, researchers say. , Limb-sparing ... bone or soft-tissue sarcomas, but the analysis by Canadian researchers ...
... Pain therapy for cancer patients whether inpatient or ... the use of an innovative electronic system combined ... been successfully tested. The treatment of the patients showed ... addition, patients reported having less pain. The results of ...
... delivery for older adults developed by researchers from Indiana ... of life, decreased emergency department visits and lowered hospital ... saved money for the sickest (those with three to ... year after the home-based intervention ended, it saved even ...
Cached Medicine News:Health News:New Mexico Seniors to Lose $130.2 Million in Medicare Long Term Care Funding in House Healthcare Reform Bill 2Health News:Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction 2Health News:Taking dex can improve high altitude exercise capacity in certain climbers 2Health News:Taking dex can improve high altitude exercise capacity in certain climbers 3Health News:Limb-Sparing Surgery May Offer Little Benefit to Cancer Patients 2Health News:Computer system improves pain therapy for cancer patients 2Health News:Aging with GRACE: New health care delivery model improves outcomes, saves money 2Health News:Aging with GRACE: New health care delivery model improves outcomes, saves money 3